Great Point Partners Lowered Holding in Neurocrine Biosciences Cmn (NBIX) as Valuation Rose; Suntrust Bks (Call) (STI) Share Price Rose While Css Has Lowered Stake

May 20, 2018 - By Lawrence Diaz

SunTrust Banks, Inc. (NYSE:STI) Logo

Jeffrey Jay decreased its stake in Neurocrine Biosciences Inc Cmn (NBIX) by 15.79% based on its latest 2017Q4 regulatory filing with the SEC. Great Point Partners Llc sold 75,000 shares as the company’s stock rose 13.16% while stock markets declined. The hedge fund run by Jeffrey Jay held 400,000 shares of the health care company at the end of 2017Q4, valued at $31.04 million, down from 475,000 at the end of the previous reported quarter. Great Point Partners Llc who had been investing in Neurocrine Biosciences Inc Cmn for a number of months, seems to be less bullish one the $8.38B market cap company. The stock increased 0.82% or $0.76 during the last trading session, reaching $93.25. About 500,268 shares traded. Neurocrine Biosciences, Inc. (NASDAQ:NBIX) has risen 91.92% since May 20, 2017 and is uptrending. It has outperformed by 80.37% the S&P500.

Css Llc decreased its stake in Suntrust Bks Inc (Call) (STI) by 90.55% based on its latest 2017Q4 regulatory filing with the SEC. Css Llc sold 464,600 shares as the company’s stock rose 1.41% while stock markets declined. The institutional investor held 48,500 shares of the finance company at the end of 2017Q4, valued at $3.13M, down from 513,100 at the end of the previous reported quarter. Css Llc who had been investing in Suntrust Bks Inc (Call) for a number of months, seems to be less bullish one the $32.25 billion market cap company. The stock decreased 1.05% or $0.73 during the last trading session, reaching $68.65. About 1.80 million shares traded. SunTrust Banks, Inc. (NYSE:STI) has risen 22.73% since May 20, 2017 and is uptrending. It has outperformed by 11.18% the S&P500.

Css Llc, which manages about $2.03 billion US Long portfolio, upped its stake in Tesla Inc (Prn) by 3.50 million shares to 12.26 million shares, valued at $12.98M in 2017Q4, according to the filing. It also increased its holding in Sina Corp (NASDAQ:SINA) by 9,318 shares in the quarter, for a total of 275,407 shares, and has risen its stake in Incyte Corp (Put) (NASDAQ:INCY).

Among 35 analysts covering Suntrust Banks Inc. (NYSE:STI), 16 have Buy rating, 0 Sell and 19 Hold. Therefore 46% are positive. Suntrust Banks Inc. had 118 analyst reports since July 20, 2015 according to SRatingsIntel. The stock of SunTrust Banks, Inc. (NYSE:STI) has “Hold” rating given on Thursday, August 27 by Evercore. The stock of SunTrust Banks, Inc. (NYSE:STI) has “Outperform” rating given on Friday, January 8 by Bernstein. On Wednesday, January 11 the stock rating was initiated by UBS with “Neutral”. The rating was upgraded by Portales Partners on Tuesday, June 28 to “Outperform”. The stock of SunTrust Banks, Inc. (NYSE:STI) has “Buy” rating given on Thursday, September 17 by Deutsche Bank. The rating was upgraded by Sandler O’Neill to “Buy” on Monday, January 23. Keefe Bruyette & Woods maintained the stock with “Hold” rating in Monday, June 5 report. Robert W. Baird maintained it with “Hold” rating and $55.0 target in Friday, August 25 report. The stock of SunTrust Banks, Inc. (NYSE:STI) has “Hold” rating given on Tuesday, January 2 by Barclays Capital. Citigroup maintained it with “Neutral” rating and $43 target in Wednesday, October 21 report.

Analysts await SunTrust Banks, Inc. (NYSE:STI) to report earnings on July, 20. They expect $1.29 EPS, up 25.24% or $0.26 from last year’s $1.03 per share. STI’s profit will be $605.93M for 13.30 P/E if the $1.29 EPS becomes a reality. After $1.29 actual EPS reported by SunTrust Banks, Inc. for the previous quarter, Wall Street now forecasts 0.00% EPS growth.

Since January 23, 2018, it had 2 insider buys, and 5 sales for $1.53 million activity. Chancy Mark A sold 7,500 shares worth $525,975. $395,760 worth of SunTrust Banks, Inc. (NYSE:STI) was bought by VOORHEES STEVEN C on Friday, May 4. Scanlan Agnes Bundy had sold 1,500 shares worth $101,025. SCRUGGS FRANK P JR also bought $69,010 worth of SunTrust Banks, Inc. (NYSE:STI) on Wednesday, May 16. Johnson Susan S had sold 3,600 shares worth $255,737 on Tuesday, February 20.

Investors sentiment increased to 1.09 in Q4 2017. Its up 0.18, from 0.91 in 2017Q3. It improved, as 38 investors sold STI shares while 239 reduced holdings. 100 funds opened positions while 202 raised stakes. 381.57 million shares or 1.65% more from 375.36 million shares in 2017Q3 were reported. Envestnet Asset Management Inc accumulated 94,229 shares. Congress Asset Management Ma, Massachusetts-based fund reported 703,790 shares. First Personal Fincl Svcs owns 916 shares. Partnervest Advisory Svcs Llc has invested 0.22% in SunTrust Banks, Inc. (NYSE:STI). Japan-based Asset One Limited has invested 0.12% in SunTrust Banks, Inc. (NYSE:STI). Moreover, Royal Commercial Bank Of Canada has 0.09% invested in SunTrust Banks, Inc. (NYSE:STI). Meiji Yasuda Asset Mgmt Ltd invested 0.08% in SunTrust Banks, Inc. (NYSE:STI). Advantus Mngmt holds 0.08% of its portfolio in SunTrust Banks, Inc. (NYSE:STI) for 47,950 shares. Parkside Fin National Bank And holds 3,710 shares. Nomura Asset Mgmt accumulated 83,207 shares or 0.06% of the stock. Shell Asset accumulated 32,001 shares or 0.04% of the stock. Mufg Americas Holdg Corp reported 108 shares or 0% of all its holdings. Ohio-based Gateway Invest Advisers Lc has invested 0.02% in SunTrust Banks, Inc. (NYSE:STI). Benjamin F Edwards And Company invested in 11,121 shares. Price T Rowe Associate Md owns 928,868 shares for 0.01% of their portfolio.

Another recent and important SunTrust Banks, Inc. (NYSE:STI) news was published by Bizjournals.com which published an article titled: “Growth plans: Both big and small banks set to expand locally” on April 26, 2018.

Investors sentiment decreased to 1.31 in 2017 Q4. Its down 0.35, from 1.66 in 2017Q3. It turned negative, as 18 investors sold NBIX shares while 76 reduced holdings. 58 funds opened positions while 65 raised stakes. 91.25 million shares or 1.56% less from 92.69 million shares in 2017Q3 were reported. Renaissance Tech Ltd Co holds 387,241 shares. Voloridge Investment Limited Liability accumulated 140,756 shares. Hsbc Hldgs Public Limited owns 5,765 shares. Schroder Inv Group Inc has invested 0% in Neurocrine Biosciences, Inc. (NASDAQ:NBIX). Voya Inv Mgmt Ltd Liability Com owns 56,583 shares or 0.01% of their US portfolio. State Street has invested 0.01% of its portfolio in Neurocrine Biosciences, Inc. (NASDAQ:NBIX). Tekla Cap Ltd Llc owns 0.97% invested in Neurocrine Biosciences, Inc. (NASDAQ:NBIX) for 325,067 shares. Legal And General Gp Public Ltd reported 0% in Neurocrine Biosciences, Inc. (NASDAQ:NBIX). Winfield Associates owns 15 shares. Group One Trading LP holds 0.01% of its portfolio in Neurocrine Biosciences, Inc. (NASDAQ:NBIX) for 16,092 shares. 37,000 were accumulated by Sphera Funds Mngmt. Moreover, Sectoral Asset has 1.38% invested in Neurocrine Biosciences, Inc. (NASDAQ:NBIX). Artal Grp invested in 0.29% or 250,000 shares. Victory Capital Mgmt reported 0% stake. First Republic Management has 23,611 shares.

Among 13 analysts covering Neurocrine Biosci (NASDAQ:NBIX), 13 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Neurocrine Biosci had 58 analyst reports since August 18, 2015 according to SRatingsIntel. The rating was maintained by Barclays Capital with “Overweight” on Thursday, November 2. The rating was reinitiated by Jefferies with “Buy” on Tuesday, August 18. The rating was maintained by Needham with “Buy” on Friday, September 15. H.C. Wainwright maintained it with “Buy” rating and $13000 target in Friday, August 4 report. The company was maintained on Friday, July 21 by BMO Capital Markets. Oppenheimer initiated Neurocrine Biosciences, Inc. (NASDAQ:NBIX) on Tuesday, November 22 with “Perform” rating. Piper Jaffray maintained the stock with “Buy” rating in Thursday, August 24 report. Oppenheimer maintained the shares of NBIX in report on Tuesday, March 13 with “Buy” rating. Robert W. Baird maintained it with “Outperform” rating and $100 target in Tuesday, May 1 report. The firm earned “Outperform” rating on Friday, January 27 by Oppenheimer.

More notable recent Neurocrine Biosciences, Inc. (NASDAQ:NBIX) news were published by: Streetinsider.com which released: “UPDATE: Neurocrine Bio. (NBIX) PT Raised to $120 at Oppenheimer” on May 14, 2018, also Globenewswire.com with their article: “Factors of Influence in 2018, Key Indicators and Opportunity within Fred’s, Nexstar Broadcasting Group, CNO Financial …” published on May 14, 2018, Streetinsider.com published: “Baird KOL Panel Says Neurocrine Biosciences’ (NBIX) Opportunity Could Be Double Expectations” on May 16, 2018. More interesting news about Neurocrine Biosciences, Inc. (NASDAQ:NBIX) were released by: Benzinga.com and their article: “Benzinga’s Daily Biotech Pulse: ASCO Abstracts, Fibrocell, Ispen And More” published on May 17, 2018 as well as Fool.com‘s news article titled: “3 Top Biotech Stocks to Buy in May” with publication date: May 09, 2018.

Since January 2, 2018, it had 0 buys, and 24 selling transactions for $40.25 million activity. The insider BENEVICH ERIC sold $68,174. 23,650 Neurocrine Biosciences, Inc. (NASDAQ:NBIX) shares with value of $2.13 million were sold by Gano Kyle. GORMAN KEVIN CHARLES sold 3,750 shares worth $295,820. 18,084 shares were sold by Lloyd-Smith Malcolm, worth $1.40 million. Nevinny Corinne H also sold $415,625 worth of Neurocrine Biosciences, Inc. (NASDAQ:NBIX) on Monday, May 7. 2,262 shares were sold by Bozigian Haig P., worth $187,977.

Neurocrine Biosciences, Inc. (NASDAQ:NBIX) Institutional Positions Chart

- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Posts

>